Barely Significant
← all excerpts

Clinical outcomes of tocilizumab therapy in polyarticular and systemic juvenile idiopathic arthritis: a single-center analysis (2018-2022).

Rheumatol Int · 2024 · PMC11618174 · PMID 39311914

Europe PMCDOI
1
hedged sentence
0.0530
closest p · 1.1× alpha
0.0530
boldest claim

The sentences

borderline significantp = 0.053so close (0.05 < p ≤ 0.1)
This difference was borderline significant for ESR ( p = 0.053) and statistically significant for WBC ( p = 0.011) and neutrophils count ( p = 0.008) (Table 1 ).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.